Brief: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
07/11/2024 12:16
Nov 7 (Reuters) - Dogwood Therapeutics Inc DWTX.O :
* DOGWOOD THERAPEUTICS ANNOUNCES THIRD QUARTER 2024
FINANCIAL
RESULTS
* DOGWOOD THERAPEUTICS INC: QTRLY LOSS PER SHARE $2.05
Source text: ID:nGNX9G3Cvv
Further company coverage: DWTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study